Addison O'Dea, writer and director of the new virtual reality show "Discovery TRVLR," discussed how his team used VR on the series. The show takes "travelers" across the globe with help from a virtual reality headset. O'Dea discusses the impact the technology has on the art of filmmaking and how immersive the experience becomes for both the subject and the viewer. He calls a virtual reality camera a "truth machine" adding that it forces him as a director to almost take a backseat in the process because it captures things as they happen. He shared the process of casting for the show, as each episode follows a different person with a specific role in their community. The characters are labeled in the series as "explorers," "guru," and "entertainer," depending on their occupation. O'Dea talks the future of VR when it comes to making media and his current focus on using the medium in upcoming projects.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More